Orion180 Insurance (OIG) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 5 analyst targets
6 firms have rated Orion180 Insurance Group (OIG) in the last 3 months: 5 buy, 1 hold and 0 sell. Their average 12-month price target is $14.98, 44.9% above a share price of $10.34, ranging from $12.90 (Deutsche Bank) to $20 (Citizens). No firm has changed its rating in that time.
Recent analyst ratings
Last 3 months| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Raymond James | Initiated Coverage | Market Perform | — | Oct 13, 2026 |
| RBC Capital | Initiated Coverage | Outperform | $15.00 | Oct 13, 2026 |
| Goldman Sachs | Initiated Coverage | Buy | $13.00 | Oct 13, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $20.00 | Oct 13, 2026 |
| Deutsche Bank | Initiated Coverage | Buy | $12.90 | Oct 13, 2026 |
| UBS | Initiated Coverage | Buy | $14.00 | Oct 13, 2026 |
Frequently asked questions
What is the price target for OIG stock?
The average 12-month analyst price target for Orion180 Insurance (OIG) is $14.98, with a high estimate of $20.00 and a low of $12.90, across 5 analysts.
Is OIG a buy, sell, or hold?
Analysts covering Orion180 Insurance currently average a Buy rating: 5 buy, 1 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for OIG?
The average price target of $14.98 implies 45.72% upside from the last price of $10.28.
Who has the highest and lowest price target for OIG?
Among the price targets analysts have published for Orion180 Insurance in the last 3 months, the highest is $20.00 from Citizens and the lowest is $12.90 from Deutsche Bank.
Has OIG been upgraded or downgraded recently?
No. Orion180 Insurance has had no analyst upgrades or downgrades in the last 3 months.
What is the latest analyst rating on OIG?
On Oct 13, 2026, Raymond James initiated coverage of Orion180 Insurance at Market Perform.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

